|
|
|
|
| Cautious Optimism For Biotechs And Their Outsourcing Partners | Guest Column | By Justin Culbertson, RSM US LLP | Pre-revenue — including preclinical and clinical stage — biotechs have been the most impacted but also stand to gain the most after the economic downturn and subsequent recovery. This article will delve into how small to midsize pre-revenue biotechs have been specifically impacted and what this could mean for organizations that support them. |
|
|
|
| Achieving Excellence In IO Clinical Trials | White Paper | By Erin Finot, IQVIA Biotech | Immuno-oncology therapies have revolutionized the treatment of cancer patients worldwide. Learn how to plan for success and reduce risk when developing novel treatments for patients with cancer. |
|
|
| Getting To The Heart Of Decision-Making In Oncology | Infographic | Oracle Life Sciences | Get the support your team needs to combine science and psychology and better identify decision-making drivers in oncology to deliver clear business impact more efficiently. |
|
|
|
|
|
|
| End-To-End Safety Solutions Designed For Success | Data Sheet | IQVIA Safety & Regulatory Compliance | As one of the world’s largest and most experienced safety and PV organizations, unearth how this provider is bringing extensive expertise and regulatory intelligence to every industry engagement. |
|
|
CHOOSE YOUR OWN ADVENTURE |
|
|
|
| You're receiving the Thursday edition of the Clinical Leader newsletter, focusing on Outsourcing Models and Regulatory & Compliance. To make changes to your newsletter selections, update your topic preferences. - Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
- Clinical Trial Technology (Tuesday)
- Decentralized Trials | Trial Management (Wednesday)
- Outsourcing Models | Regulatory & Compliance (Thursday)
- Clinical Data Management & Analytics | Trial Monitoring (Friday)
Learn more about our personalized newsletters here. |
|
|
| Connect With Clinical Leader: |
|
|
|
